- Home
- AVTX vs JVSA Comparison
AVTX vs JVSA Comparison
Compare AVTX & JVSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVTX
- JVSA
- Stock Information
- Founded
- AVTX 2011
- JVSA 2021
- Country
- AVTX United States
- JVSA Hong Kong
- Employees
- AVTX N/A
- JVSA N/A
- Industry
- AVTX Biotechnology: Pharmaceutical Preparations
- JVSA
- Sector
- AVTX Health Care
- JVSA
- Exchange
- AVTX Nasdaq
- JVSA NYSE
- Market Cap
- AVTX 90.9M
- JVSA 79.7M
- IPO Year
- AVTX 2015
- JVSA 2024
- Fundamental
- Price
- AVTX $10.13
- JVSA $10.38
- Analyst Decision
- AVTX Buy
- JVSA
- Analyst Count
- AVTX 2
- JVSA 0
- Target Price
- AVTX $35.00
- JVSA N/A
- AVG Volume (30 Days)
- AVTX 59.3K
- JVSA 725.0
- Earning Date
- AVTX 11-07-2024
- JVSA 01-01-0001
- Dividend Yield
- AVTX N/A
- JVSA N/A
- EPS Growth
- AVTX N/A
- JVSA N/A
- EPS
- AVTX N/A
- JVSA 0.24
- Revenue
- AVTX $820,000.00
- JVSA N/A
- Revenue This Year
- AVTX N/A
- JVSA N/A
- Revenue Next Year
- AVTX N/A
- JVSA N/A
- P/E Ratio
- AVTX N/A
- JVSA $42.90
- Revenue Growth
- AVTX N/A
- JVSA N/A
- 52 Week Low
- AVTX $3.95
- JVSA $10.02
- 52 Week High
- AVTX $34.46
- JVSA $10.42
- Technical
- Relative Strength Index (RSI)
- AVTX 37.71
- JVSA N/A
- Support Level
- AVTX $12.00
- JVSA N/A
- Resistance Level
- AVTX $13.59
- JVSA N/A
- Average True Range (ATR)
- AVTX 0.96
- JVSA 0.00
- MACD
- AVTX -0.50
- JVSA 0.00
- Stochastic Oscillator
- AVTX 17.42
- JVSA 0.00
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical stage biotechnology company focused on the treatment of immune dysregulation. The company's lead asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).
About JVSA JVSPAC ACQUISITION CORP
JVSPAC Acquisition Corp is blank check company.